Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Denosumab biosimilar by Gedeon Richter for Post Menopausal Osteoporosis: Likelihood of Approval
Denosumab biosimilar is under clinical development by Gedeon Richter and currently in Phase III for Post Menopausal Osteoporosis. According to...
Data Insights
Estetrol by Gedeon Richter for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Estetrol is under clinical development by Gedeon Richter and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to...